My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
July/August 2015
EDUCATION AND RESOURCES
Latest OFID Podcast Features Martin Blaser on the Microbiome

In the sixth installment of the Open Forum Infectious Diseases (OFID) podcasts, Editor in Chief Paul Sax, MD, FIDSA, speaks with IDSA Past President Martin Blaser, MD, FIDSA, of New York University about the overuse of antibiotics in the United States and the consequential impact on the human microbiota. They discuss how using antibiotics in excess can be linked to host of diseases plaguing humans today – from obesity and allergic diseases, to certain cancers.

Dr. Blaser is Muriel and George Singer Professor of Medicine and Professor of Microbiology at NYU, director of the Human Microbiome Program, and author of the book Missing Microbes: How the overuse of antibiotics is fueling our modern plagues. His accolades include founding the Foundation for Bacteriology and the Virtual Museum of Bacteria, and serving as chair of the Board of Scientific Counselors of the National Cancer Institute and of the Advisory Board for Clinical Research at the National Institutes of Health. In 2014, IDSA presented him with the Alexander Fleming Award for Lifetime Achievement.

IDSA launched OFID in 2014 in partnership with Oxford University Press to offer the rapid publication of clinical, translational, and basic research for all aspects of infectious diseases, with a focus on studies that have the potential to improve patient care. Now indexed in PMC, the journal is fully peer-reviewed and freely accessible to all readers.

To submit your manuscript, read the Instructions for Authors and submit online.



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
Guideline on Diagnosis and Management of Vertebral Osteomyelitits Released
CDC Updated Guidelines on Treatment of Sexually Transmitted Diseases
FDA Approves Technivie in Combination with Ribavirin for Treatment of HCV
CLINICAL PRACTICE MANAGEMENT
CMS Issues FAQ Document on ICD-10 Implementation
POLICY AND ADVOCACY
White House Releases Five-Year HIV/AIDS Strategy
21st Century Cures Act Progresses Through Congress
House, Senate Committees Recommend 2016 Funding to Address Antibiotic Resistance
News from CDC: Recognizing the 20th Anniversary of the Emerging Infections Program
NIH Requests Input on its Strategic Plan
IDSA Comments on Criteria for $20 Million CARB Diagnostics Challenge
FDA Proposal Would Yield Better Data on Antibiotics in Meat, Poultry
GLOBAL ID
Science Speaks Covers 8th International AIDS Conference
EDUCATION AND RESOURCES
What Not to Miss at IDWeek 2015
OFID Offers Special Peer Review Track for Fellows of IDSA (FIDSA)
Latest OFID Podcast Features Martin Blaser on the Microbiome
YOU AND YOUR COLLEAGUES
FIDSA Designees Announced: 113 Distinguished Physicians, Scientists Honored
Members on the Move
Member Report
From the President
Setting IDSA’s Course to Lead the Future of ID
TOP STORIES
IDSA Compensation Survey: Take 5 Minutes to Help Us Advocate for You
Take Part in IDSA’s Future: Cast Your Vote in Board Elections
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.